1. Home
  2. INHD vs NKGN Comparison

INHD vs NKGN Comparison

Compare INHD & NKGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INHD
  • NKGN
  • Stock Information
  • Founded
  • INHD 2019
  • NKGN 2017
  • Country
  • INHD United States
  • NKGN United States
  • Employees
  • INHD N/A
  • NKGN N/A
  • Industry
  • INHD
  • NKGN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INHD
  • NKGN Health Care
  • Exchange
  • INHD Nasdaq
  • NKGN Nasdaq
  • Market Cap
  • INHD 12.8M
  • NKGN 14.1M
  • IPO Year
  • INHD 2023
  • NKGN N/A
  • Fundamental
  • Price
  • INHD $4.50
  • NKGN $0.50
  • Analyst Decision
  • INHD
  • NKGN
  • Analyst Count
  • INHD 0
  • NKGN 0
  • Target Price
  • INHD N/A
  • NKGN N/A
  • AVG Volume (30 Days)
  • INHD 33.6K
  • NKGN 711.5K
  • Earning Date
  • INHD 02-14-2025
  • NKGN 12-24-2024
  • Dividend Yield
  • INHD N/A
  • NKGN N/A
  • EPS Growth
  • INHD N/A
  • NKGN N/A
  • EPS
  • INHD N/A
  • NKGN N/A
  • Revenue
  • INHD $885,495.00
  • NKGN N/A
  • Revenue This Year
  • INHD N/A
  • NKGN N/A
  • Revenue Next Year
  • INHD N/A
  • NKGN N/A
  • P/E Ratio
  • INHD N/A
  • NKGN N/A
  • Revenue Growth
  • INHD 10.72
  • NKGN N/A
  • 52 Week Low
  • INHD $3.00
  • NKGN $0.20
  • 52 Week High
  • INHD $17.29
  • NKGN $4.06
  • Technical
  • Relative Strength Index (RSI)
  • INHD 43.65
  • NKGN 59.45
  • Support Level
  • INHD $4.40
  • NKGN $0.45
  • Resistance Level
  • INHD $5.12
  • NKGN $0.55
  • Average True Range (ATR)
  • INHD 0.49
  • NKGN 0.07
  • MACD
  • INHD -0.04
  • NKGN 0.00
  • Stochastic Oscillator
  • INHD 6.71
  • NKGN 47.48

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

About NKGN NKGen Biotech Inc.

NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.

Share on Social Networks: